UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04-3744954 (State or othe ...

Globus Medical, Inc. (NYSE:GMED) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants Brian Kearns - Senior Vice President-Business Development and Investor Relations Dave Demski - President and Chief Executive Officer Dan Scavilla - Executive Vice President, Chief Commercial Officer and Chief Financial Officer Conference Call Participants Larry Biegleson - Wells Fargo Richard Newitter - Leerink Mike Matson - Needham Craig Bijou - Cantor Fitzgerald Matthew O'Brien - Piper Jaffray You ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE 04 ...

Globus Medical, Inc. (NYSE:GMED) Q4 2018 Earnings Conference Call February 21, 2019 4:30 PM ET Company Participants Brian Kearns – Vice President-Business Development and Investor Relations Dave Demski – Chief Executive Officer Dan Scavilla – Executive Vice President, Chief Commercial Officer and Chief Financial Officer Anthony Williams – President Conference Call Participants Shagun Singh – Wells Fargo Craig Bijou – Cantor Fitzgerald Matt Miksic – Credit Suisse Mike Matson – Needham & Company Ryan Zimmerma ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ Commission File No. 001-35621 GLOBUS MEDICAL, INC. (Exact name of registrant as speci ...